Negotiations are ongoing in New York to agree the latest UN political declaration on non-communicable diseases (NCDs) and ...

It was by far the most difficult phone call of my life. Absolutely nothing can prepare you for telling your mother that she ...

The relationship between hormone therapy (oestrogen with or without progestogen) and breast cancer risk has been widely ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

We read with great interest the Lancet Oncology Editorial1 calling for a coordinated global approach to address the growing ...

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

In June, 2025, the UK government announced plans to boost science and technology research and development (R&D) in the country, pledging to invest £86 billion in the sector over the next 4 years. The ...

The 16th World Congress on Endometriosis held in Sydney, May 21–24, put an important but often neglected women's health condition into the spotlight. Endometriosis is a chronic disease characterised ...

Nobuaki Matsubara and colleagues1 and Andre P Fay and colleagues2 are to be congratulated for making the patient perspective an integral part of cancer drug development with patient-reported outcomes ...

Homelessness has long been associated with an elevated risk of suicide and self-harm, but previous studies have largely been restricted to selected patient groups, such as those presenting to hospital ...

One small city's bid to rescue its health finances has transformed the way health care is managed across China. Chris McCall ...

The House of Commons has approved the Terminally Ill Adults Bill amid narrowing support and ongoing debate. Jacqui Thornton reports.